bluuebunny/crossref_metadata_2025_split huggingface dataset:
Relationship between emotional intelligence and neurocognition in severe mental disorders
Authors: Chapela E. , Morales I. , Quintero J. , Félix-Alcántara M. , Correas J. , Gómez-Arnau J. 
Published: May 2016

IntroductionThe severe mental disorders are the subject of growing research in the area of emotional intelligence because of his relationship with psychosocial functionality loss. Despite treatment advances, patients continue to experience high levels of social, professional and personal disabilities, related to the presence of deficits in cognition. These changes are manifested in two areas: the neurocognitive and social cognition.ObjectivesTo better understand the relationship between neuro- and sociocognition in schizophrenia and bipolar disorder.AimsThe aim of this research is to study the factors related to emotional intelligence, with particular interest in neurocognitive deficits.MethodsA total of 75 adult patients with schizophrenia and bipolar disorder type I were evaluated. The assessment protocol consisted of a questionnaire on socio-demographic and clinical-care data, and a battery of clinical and cognitive scales, including MSCEIT, WAIS-IV, TMT and Rey Figure.ResultsMSCEIT was negatively correlated with age, the severity of the clinical symptoms (BPRS, CGI-S), the TMT-A and the Test of Complex Figure, and positively with the intelligence quotient.ConclusionsThe deficits in emotional intelligence are part of a set of cognitive, social and non-social skills, which are altered in these severe mental disorders. Emotional intelligence worsens with the deterioration of cognitive functioning, executive dysfunction and severity of psychiatric disorder.Disclosure of interestThe authors have not supplied their declaration of competing interest.
Inconsistent decline of executive functions in patients with early and late Huntington's disease
Authors: Mörkl S. , Blesl C. , Tmava A. , Wurm W. , Holl A. , Painold A. 
Published: May 2016

BackgroundHuntington's disease (HD) is characterized by executive dysfunctions like problems with planning, accuracy, inhibition and impulsivity. During the course of the disease executive function worsens with ongoing pathological changes in the basal ganglia. However, it is not clear whether cognitive dysfunction develops gradually or not during the course of the disease.MethodsWe assessed the development of executive dysfunction in 23 patients with early HD and 29 patients with late HD on the Tower of London (ToL) for the number of solved problems, planning time and number of breaks.ResultsHD patients showed a linear decrease of accuracy (as assessed by number of solved problems) during the course of the disease. Controls scored significantly higher than early stage HD patients and early stage HD patients scored significantly higher than late stage HD patients. In planning time and number of breaks a non-linear decrease was found.ConclusionExecutive dysfunctions in HD are not alone connected to degenerative changes in the striatum as they do not develop gradually and linear during the course of the disease. Obviously, executive function could not be seen as a single component, but as a combination of different abilities, which show a non-linear and non-parallel decline.Disclosure of interestThe authors have not supplied their declaration of competing interest.
Neuropsychiatric manifestations of vitamin B12 and folate deficiencies: Data from an inpatient psychiatric department
Authors: Mota A. , Lázaro M. , Alves R. , Moreira A. , Nobre M. 
Published: May 2016

IntroductionThe prevalence of vitamin B12 and folate deficiency is significant in the psychiatric population. These deficiencies may be associated with varied neuropsychiatric signs and symptoms, caused by different pathophysiological mechanisms.ObjectivesCharacterize the main neuropsychiatric signs and symptoms associated with vitamin B12 and folate deficiencies. Evaluate the prevalence of these vitamins deficiencies in an acute inpatient psychiatric department, dedicated to Affective Disorders.AimsTo review the clinical significance of vitamin B12 and folate deficiencies in psychiatric disorders and reflect on the importance of routine screening in mental health care.Material and methodsObservational, retrospective and descriptive study, with analysis of clinical and blood tests data concerning the total number of inpatient episodes in 2015. Non-systematic review of the scientific literature.ResultsA small case series of the patients that had folate or B12 deficiency detected is presented. The prevalence of vitamin B12 and folate deficiencies found in our study is in accordance with the data found in the literature.ConclusionsVitamin B12 and folate deficiencies should be considered in the approach to the psychiatric patient as its neuropsychiatric manifestations are varied, can be severe, and may constitute a potentially treatable cause of mental disorder. Our data shows that folate and B12 deficiencies are significant in inpatients and we believe it justifies routine screening at admission.Disclosure of interestThe authors have not supplied their declaration of competing interest.
From clinical cases to clinical research: Neurocognition and social cognition in schizophrenia
Authors: Gurovich I. , Papsuev O. , Shmukler A. , Movina L. , Storozhakova Y. 
Published: May 2016

IntroductionNeurocognition and social cognition are the core deficits influencing social outcomes in patients with schizophrenia. These deficits are present in prodromal phase and throughout the illness, in first-degree relatives and are considered in the framework of neurodevelopmental or neurodegenerative models.MethodFour clinical cases with patients reflecting different cognitive profiles were chosen to demonstrate heterogeneity of cognitive biases and their influence on the social function en vivo. The patients have undergone a number of neurocognitive and social cognitive measures.ResultsIn these four patients, we would like to highlight the dissociation of neurocognitive deficits, clinical manifestations and social functioning. Social cognitive measures revealed heterogeneity of biases in different domains. As a result of our observation, we can hypothesize that better social functioning was achieved by patients with better abilities to discriminate negative emotions and states of mind in others.ConclusionDespite certain limitations of case-report studies, it is hard not to point out heterogeneity and incoherence of social and neurocognition. We assume that intact domains of Processing of Emotions and Theory of Mind predispose to better social functioning, while it's hard to trace this connection to neurocognition. This result needs to be challenged on large samples in future research, concerning emotionality in Theory of Mind and capacity for empathy and its’ role in social functioning.Disclosure of interestThe authors have not supplied their declaration of competing interest.
Characteristics of selected cognitive functions in patients with systemic lupus erythematosus using Cambridge neuropsychological test automated battery
Authors: Bogaczewicz A. , Kowalski J. , Ząbek J. , Wożniacka A. , Bogaczewicz J. , Sobow T. 
Published: May 2016

IntroductionCognitive dysfunction in patients with systemic lupus erythematosus affects 10–36% of them.ObjectiveTo determine a profile of selected cognitive functions in systemic lupus erythematosus.The aimTo investigate and characterize selected cognitive parameters in patients with systemic lupus erythematosus (SLE) using a standardized, comparable and reproducible computer-based method.Material and methodsThe study included 25 patients with SLE. For neuropsychological assessment, the Cambridge Neuropsychological Test Automated Battery was used. Following parameters were investigated: mean latency and mean error in motor screening (MOTML, MOTME), big little circle (BLC), paired associated learning (PAL), problems solved in minimum moves in stockings of Cambridge (SOC PSMM) and graded naming test (GNT). Results were referred automatically to determined ranges of norms matched according to age and gender.ResultsIn patients with SLE results displayed by median and upper and lower quartiles were as follows: MOTML = 1.1 (0.9–1.34), MOTME = 0.41 (0.31–0.52), BLC = 0.16 (0.16–0.18), PAL = −0.43 (−1.28; −0.18), SOCPSMM = −0.62 (−1.19–0.04), and GNT = −0.8 (−1.6; −0.32).MOTML correlated negatively with MOTME (r = −0.51), MOTME correlated with SOCPSMM (r = 0.41), and PAL correlated with GNT (r = 0.48) (P < 0.05).ConclusionsIn our study, predominant abnormalities were those related to lexical and semantic memory, revealed by the GNT, spatial planning and spatial working memory, assessed by the SOC, together with visual memory and new learning, assessed with the PAL.Disclosure of interestThe authors have not supplied their declaration of competing interest.
Psychosis, cause or consequence of substance use disorder
Authors: Cancino Botello M.C. , Canseco Navarro M.D.L.A. , Peña Serrano A. , Molina López F. , Hernández Sánchez J.M. 
Published: May 2016

IntroductionThe use of psychostimulants, such as amphetamines and cocaine in psychotic patients is 4 times more frequent than non-psychotic ones. It is believed that people with psychosis may use substances as a self-treatment for negative symptoms. However, early onset of substance use disorder can develop psychotic and/or negative symptoms, leading to confusion between primary or secondary psychosis.MethodSystematic review of the literature in English (PubMed) and patient's clinical record. Keywords: “Substance use disorder”; “psychosis”.Objectivesto highlight the importance of an adequate characterization of psychotic symptoms in patients with substance use disorder.CaseA 29-year-old man, with psychostimulants and cannabis abuse since adolescence and very short abstinence episodes. Later on, he developed paranoia symptoms that slightly improved once he decreased drugs dosage, but they were still present even on complete abstinence. Over the last year he has showed negative and psychotic symptoms that have been worsening with aggressive behavior during the last months, so he had to be hospitalized. During this period, he has been treated successfully with aripiprazol depot once monthly. His evolution has been positive, it has disappeared psychotic symptoms and paranoia, and after discharge he has managed to remain abstinent to psychostimulants.ConclusionsAdequate characterization of patients with psychotic symptoms and substance abuse is essential to determine whether the psychotic disorder is associated with primary or induced TUS. Therefore, it is essential a thorough clinical evaluation to make an accurate diagnosis and to draw an individualized treatment plan.Disclosure of interestThe authors have not supplied their declaration of competing interest.
Psychiatric disorders among asthmatic patients: Literature review
Authors: Moreira C.A. , Marinho A.M. , Gil L.C. , Bairrão M. , Queiroz L. 
Published: May 2016

IntroductionAsthma is a major public health problem and its prevalence has increased in both developed and developing countries during the last few years. Once it is a chronic illness, it has also revealed psychological consequences. Moreover, recent studies have suggested an association between asthma (especially of severe grade) and mental disorders.ObjectivesThe authors pretend to make a brief review concerning psychiatric disorders among asthmatic patients.AimsTo understand and to be able to deal with the psychiatric disorders among chronic asthmatic patients.MethodsThe review was based on scientific documentation published in PubMed database, using the following terms as keywords: “asthma”, “depression”, “anxiety” and “panic disorder”.ResultsCompared to the general population, both anxiety and mood disorders rates are at least two times those observed in asthmatic patients. Moreover, certain psychiatric disorders rates, including panic disorder (PD) and major depressive disorder, are as much as six times more prevalent among asthmatics when compared to the general population. The association between psychiatric disorders and poor asthma control and asthma-related quality of life could occur through several pathways, such as behavioural pathways; cognitive or perceptual pathways; or through the direct physiological effects of depression and anxiety on the autonomic nervous system (ANS) and immune systems which increase asthma symptomatology.Discussions/ConclusionsThere is a close correlation between anxiety, PD and depression, and a poor controlled asthma. A better understanding of this association may have major clinical implications, mainly in patients with poor controlled asthma in whom the presence of anxiety and depression should be investigated.Disclosure of interestThe authors have not supplied their declaration of competing interest.
Prevalence of problematic alcohol consumption in patients with anxiety of depressive disorders
Authors: García Mahía M.D.C. , Fernández Quintana Á. 
Published: May 2016

IntroductionDepression and alcohol problems are common in psychiatric outpatients, but there are few studies including patients with anxiety disorders.AimsTo study the prevalence of problematic alcohol consumption in a sample of patients diagnosed of anxiety or depressive disorder and treated in a mental health clinic and to analyze clinical and sociodemographic variables associated to alcohol consumption.MethodsThe sample studied included 194 outpatients (31.9% men and 68.1% women) treated in an outpatient clinic and diagnosed of any anxiety or depressive disorder included in DSM-IVTR as main diagnose. Instruments used were Beck Depression Inventory (BDI), and the Alcohol Use Identification Test (AUDIT). Other variables studied included age, civil status, level of studies, and specific psychiatric diagnoses.ResultsA total of 64.9% were diagnosed of anxiety disorder and 35.1% were diagnosed of depressive disorder. The prevalence of problematic alcohol consumption was 7.8%, being more frequent in men, especially in men and in middle ages. Problematic alcohol consumption was found with more frequency in patients with generalized anxiety disorder and major depression, in this order. Patients with other comorbidity disorders in Axis II presented the highest prevalences of problematic alcohol consumption.ConclusionsProblematic alcohol consumption presents high prevalence in patients with anxiety or depressive disorders and dual diagnose usually is associated with poor prognosis. It is necessary to make efforts to detect alcohol problematic consumption in psychiatric patients and develop specific treatment programs directed to this group of patients in both primary and specialized care units.Disclosure of interestThe authors have not supplied their declaration of competing interest.
Mental disturbances in patients with acute medical condition
Authors: Fedak B. 
Published: May 2016

Contemporary remains understudied health issue - the psychological aspect of the acute therapeutic diseases problem. Among the most common diseases - coronary heart disease (CHD), myocardial infarction (MI), crisis states in patients with arterial hypertension (AH), transient ischemic attack (TIA) and acute stroke (AS), gastric ulcer and duodenal ulcer (GU&DU). Clinical features of the structure, dynamics, current and immediate link with the medical conditions is not fully understood. The basis of our research, the purpose of which, was to identify mental disturbances in patients with acute therapeutic diseases. One hundred and eighty-seven patients were examined, 34 CHD patients, 37–MI, 38 - TIA, 39–AH, 39 - GU&DU, 65% male and 35% female aged 20 to 60 years. The main research method was clinical and psychopathological. A high-level affective and neurotic disorders in these patients was observed. Structured analysis allowed identifying four main options disturbances: nosogenic neurotic reaction–68 patients; somatogenic asthenic syndrome–46 patients; reaction psychological maladjustment–34 patients; acute stress reactions–39 patients. Stratification of structure psychopathological syndroms allowed systematizing them in 4 different groups: asthenic–24%; anxiety - 46%; subdepressive - 11%; somatoform - 19%. That was the basis for the determination early psychotherapeutic correction program, formed by integrative model. The high efficacy was shown in 74% patients, middle range–in 15%, low–in 11% patients.Disclosure of interestThe authors have not supplied their declaration of competing interest.
Anxiety and depression in haemodialysis patients in relation to dialysis adequacy and nutritional status
Authors: Cui Xi L. , Michael G. , Chen Z. , Anuar N.H.M. , Yong K.H.M. , Tagore R. 
Published: May 2016

IntroductionAnxiety and depression are distinct clinical entities associated with mortality in haemodialysis (HD) patients.AimsThis study aims to identify the prevalence of anxiety and depression in HD patients and uncover the association of anxiety and depression in relation to the dialysis adequacy and nutritional status.ObjectiveThis would help reinforce early detection and treatment to improve quality of life and patient's outcome in HD treatment.MethodForty HD patients were assessed for anxiety and depression with the Generalised Anxiety Disorder Assessment (GAD-7 and Patient Health Questionaire [PHQ-9]). The scores of GAD-7 and PHQ-9 were correlated with the demographic, clinical and laboratory variables and nutritional status assessed by a dietician through the Subjective Global Assessment (SGA).ResultsOut of the 40 HD patients, 7 (17.5%) were anxious and 15 (37.5%) were depressed. Patients were more anxious and less depressed with better nutrition. They were less anxious and depressed with increasing albumin levels, Charlston comorbidity index based on combined condition and age-related score and Kt/V. The univariate logistic regression analysis showed only a significant inverse correlation between depression and albumin level (P = 0.041, OR = 0.88 [95% CI = 0.78 to 0.99]) and Kt/V (P = 0.054, OR = 0.03 [95% CI = 0.01 to 1.07]).ConclusionDepression is more prevalent than anxiety in HD patients. The risk of depression also increases with poorer dialysis adequacy and nutritional status. Thus, by improving dialysis adequacy and nutritional status, we can reduce the incidence of depression. However, a significant correlation cannot be drawn for anxiety.Disclosure of interestThe authors have not supplied their declaration of competing interest.
Psychosocial outcomes 3 years after facial transplantation of a blind patient
Authors: Lemmens G. , Hendrickx H. , Poppe C. , Roche N. , Peeters P. , Vermeersch H. , Rogiers X. , Van Lierde K. , Blondeel P. 
Published: May 2016

BackgroundTo date, psychosocial outcomes after facial transplantation are promising although long-term consequences, outcome of blind patients and the impact on family members are less well investigated. The aim of this study was to examine the long-term psychosocial of a blind patient and his partner 2 and 3 years after facial transplantation.MethodsDepressive and anxiety symptoms, hopelessness, coping, resilience, illness cognitions, marital support, dyadic adjustment, family functioning and quality of life of the patient and the partner were assessed before and 2 and 3 years after transplantation. Reliable change index (RCI) was further calculated to evaluate the magnitude of change.ResultsMost psychological, marital and family scores of both the patient and the partner remained within a normative and healthy range at follow-up. Resilience (RCI: 2.5 & 3.4 respectively), affective responsiveness (RCI: −4.1 & −3.2 respectively), physical quality of life (RCI: 8.7 & 7.2 respectively) and helplessness (RCI: −2.2 & −2.9 respectively) of the patient improved at 2 and 3 years follow-up. Further, dyadic cohesion (RCI: 2.4) of the patient improved at 2 years whereas marital depth (RCI: −2.0) of the partner decreased at 3 years.ConclusionsThe results of this study point to positive long-term psychosocial outcomes of a blind patient and his partner after facial transplantation. Further, they may underscore the importance of patient selection, social support and involvement of family members in treatment.Disclosure of interestThe authors have not supplied their declaration of competing interest.
Incapacity to decide in liaison psychiatry: Analysis of sample of patients admitted in somatic departments of a general hospital
Authors: Nascimento M. , Vicente F. , Oliveira C. , Silva N. , Vieira C. , Luís A. , Maia T. 
Published: May 2016

IntroductionDecision capacity (DC) is a complex construct, whose assessment poses huge challenges to Liaison Psychiatrist (LP).Objectives/aimsAssess factors related to DC in patients with somatic disorders admitted in medical and surgical departments of a general hospital.MethodsClinical records of patients who were submitted to a DC assessment at Hospital Fernando Fonseca (Portugal), from 1st January 2012 to 31st December 2014 were retrospectively analysed. Collected data were statistically analysed with SPSS®. Univariable analysis was performed, in order to determine factors related to DC.ResultsData from 35 patients subject to DC evaluation were considered, of whom 42.4% were considered unable to give consent to medical and/or surgical procedures. Most of these assessments were related to patients who refused treatment. Patients unable to decide were predominantly male and mainly affected by organic mental or neurocognitive disorders (P < 0.05). There were no statistical significant differences in the age of those considered able or unable to decide. After PL intervention, 40% of those considered unable to decide changed their decision. However, it was not significantly related to the ability to give consent.ConclusionsNeurocognitive disorders are common diagnosis found in patients admitted in somatic departments with no DC. Frequent change in decision after LP intervention may reflect not only cognitive fluctuations, but also a possible influence of LP intervention on patients’ choices. Appropriate standardized measures are useful tools in assessing patients with cognitive impairment, reducing evaluation differences between professionals, and in order to increase LP decisions credibility.Disclosure of interestThe authors have not supplied their declaration of competing interest.
Psychiatric comorbidity and suicide risk in patients with psoriasis
Authors: Pompili M. , Innamorati M. , Erbuto D. , Costanzo A. 
Published: May 2016

IntroductionPsoriasis has a significant impact on the mental and emotional functioning.ObjectiveIt has been reported that the risk of psychiatric comorbidity increases with the severity of the disorder, and the most frequent associations appear to be those with depression and anxiety.AimsTo analyze the association between psoriasis, mental disorders and suicidal ideation in a sample of patients affected by psoriasis. To investigate the differences between psoriasis patients and patients with other dermatologic diseases.MethodsParticipants were 242 consecutive patients (142 women and 100 men), 112 patients with psoriasis (46.3%), 77 with melanoma (31.8%) and 53 with allergy (21.0%). All patients were administered a structured sociodemographic interview and the following measures: the Hamilton Rating Scale for Depression (HAM-D) and the Hamilton Rating Scale for Anxiety (HAM-A). We also assessed current and previous suicidal ideation and previous suicide attempts.ResultsPatients with psoriasis (compared to other groups of patients) more frequently had a comorbid mood disorder (16.1% vs 3.9% and 0.0%, respectively for patients with melanoma and patients with allergy; χ22 = 14.98; P < 0.001), past suicidal ideation (33.9% vs 15.6% and 18.9%, respectively for patients with melanoma and patients with allergy; χ22 = 2.05; P < 0.01) and attempts (6.3% vs 0.0% and 0.0%, for the other groups of patients; χ22 = 8.37; P < 0.05). Patients with psoriasis reported higher HAM-D scores than melanoma patients.ConclusionsThe clinical evaluation of patients with psoriasis should include the assessment of psychiatric comorbidities and the routinely assessment of suicide risk.Disclosure of interestThe authors have not supplied their declaration of competing interest.